Stopped: The study was stopped because all five participants were lost to follow-up before completing treatment or any assessments, leaving no outcome data available and making continuation of the trial infeasible.
The purpose of this study is to determine the safety and compliance of initial intravenous (IV) antibiotics followed by oral antibiotic therapy following uncomplicated IVDA endocarditis. Endocarditis has a high rate of sickness and death, involves a long hospitalization and a long-term use of IV antibiotics necessitating six (6) weeks of in-patient hospital stay, and comes with a high cost.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
All-cause Mortality at Six (6) Months Post-surgery.
Timeframe: Six months
All-cause Mortality at (12) Months Post-surgery.
Timeframe: One year
Incidence of Recurrent Blood Culture Positive Infection (6 Month)
Timeframe: Six months
Incidence of Recurrent Blood Culture Positive Infection (1 Year)
Timeframe: One year
Incidence of Cardiac Re-operation (6 Month)
Timeframe: Six months
Incidence of Cardiac Re-operation (1 Year)
Timeframe: One year